An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …

Introduction: Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by
intensely pruritic, hyperkeratotic nodules distributed on the trunk and extensor surfaces of …

Background Prurigo nodularis is a chronic, debilitating, and severely pruritic
neuroimmunologic skin disease. Nemolizumab, an interleukin-31 receptor alpha antagonist …

Prurigo nodularis (PN) is a chronic inflammatory skin disease with intensely pruritic nodules.
The LIBERTY-PN PRIME and PRIME2 phase 3 trials enrolled adults with PN with≥ 20 …

Background Prurigo nodularis is a chronic pruritic skin disease with multiple nodular skin
lesions. Nemolizumab is a monoclonal antibody targeting the interleukin-31 receptor, which …

Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by intensely
pruritic, hyperkeratotic nodules that favor the extensor surfaces of the extremities and the …

Over the past two decades, significant progress in understanding of the pathogenesis of type
2 chronic inflammatory diseases has enabled the identification of compounds for more than …

Background Prurigo nodularis (PN) is a chronic disease characterized by intensely pruritic,
raised, nodular lesions. Because there are currently no United States Food and Drug …

Pruritus is a common symptom of several skin diseases, both inflammatory and neoplastic.
Pruritus might have a tremendous impact on patients' quality of life and strongly interfere …

Prurigo nodularis (PN) is an understudied, chronic inflammatory skin disease that
disproportionately affects African Americans and presents with intensely pruritic nodules of …